| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,321 | 2,529 | 1,917 | 2,392 | | Cost of Revenue | 1,175 | 1,292 | 1,339 | 5,877 | | | Gross Profit | 1,145 | 1,236 | 578 | (3,485) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,329 | 1,445 | 747 | 959 | | Non Recurring | 392 |
-
|
-
| 1,973 | | Others | 993 | 799 | 1,308 | 5,827 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,570) | (1,008) | (1,476) | (12,244) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 191 | (1,774) | 557 | 8,307 | | Earnings Before Interest And Taxes | (2,494) | (2,786) | (801) | (4,609) | | Interest Expense | 688 | 608 | 571 | 600 | | Income Before Tax | (3,182) | (3,394) | (1,371) | (5,209) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 15 | (4) | 119 | 968 | | | | Net Income From Continuing Ops | (3,052) | (3,394) | (1,371) | (3,568) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,052) | (3,394) | (1,371) | (3,568) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,052) | ($3,394) | ($1,371) | ($3,568) |
|
0.03% Nasdaq 0.00%
Income Statement
